Nec Bio B.v

This early-stage trial is testing the safety and effects of a personalized oral vaccine called NECVAX-NEO1 when added to standard immunotherapy drugs (anti-PD-1/PD-L1) for patients with solid tumors. The vaccine is custom-made for each patient using markers from their own tumor, …